Home
1
News
2
最新消息
3
[2025/06] Exhibition announcement- LTX-568 draws global attention at the 2025 BIO International Convention4
https://www.lyntonix.com/en/ LYNTONIX, INC.
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan
Lyntonix officially joined ITRI’s Biomedical Accelerator on Sep. 14, 2026. By leveraging the accelerator’s industry resources and professional networking platform, Lyntonix aims to further strengthen its connections with industry partners, prospective collaborators, and professionals across various areas of business operations, thereby creating broader opportunities for strategic collaboration and business development. https://www.lyntonix.com/en/hot_540088.html [2026/09] News-Lyntonix Joins ITRI’s Biomedical Accelerator to Strengthen Industry Partnerships and Expand Collaboration Opportunities 2026-10-05 2027-10-05
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2026-10-05 http://schema.org/InStock TWD 0 https://www.lyntonix.com/en/hot_540088.html

LYNTONIX was honored to be one of the Taiwanese biomedical startup companies selected by NSTC to participate in 2025 US BIO, promoting our innovatice product, LTX-568. During the convention, LTX-568 attracted strong interest and received highly positive feedback from industry experts and global partners. We look forward to advancing LTX-568 into clinical studies, and conquering the unmet needs for IBS abdominal pain.






Previous Back to List Next